When it comes to a controlled environment, where the complexity of engineering, layout and performance is so vital to preventing contamination and protecting process and yield, the fundamental building blocks of a project simply cannot be ignored.
To deliver treatments for rare diseases more quickly, companies share how they are adapting their launch strategies and engaging more deeply with physicians and experts.
Thames Freeport, in collaboration with Rainmaking and Care City, has launched their health and care accelerator with a cohort of six innovative Korean startups, each tackling critical health and care challenges facing the UK’s ageing population.
Johnson & Johnson has announced data from the Phase 3 ASTRO study of TREMFYA (guselkumab) subcutaneous (SC) induction therapy in adults with moderately to severely active ulcerative colitis (UC).
The Indian Contract Research, Development, and Manufacturing Organisation (CRDMO) sector is at an inflection point, with the potential to grow to $22 - $25 billion by 2035, as revealed in a new report, Unleashing the Tiger: Indian CRDMO Sector 2025.
Datapharm, a provider of medicines information in the UK, has announced its continued expansion into Europe through a new strategic partnership with VIDAL.
Ideal for companies within the pharmaceutical and life sciences industries, the solution hopes to solve counterfeit medicine trafficking and false counterfeit challenges.
Sphere Fluidics has announced its rebranding to Sphere Bio.
Dmitry Demidovich Shutterstock
The name change marks a significant milestone in the Company’s development, reflecting its transition from a leading
ProductLife Group (PLG) has announced the acquisition of HERAX Life Science, a Danish business and technology consultancy providing tailored services and solutions for the life sciences industry.
